메뉴 건너뛰기




Volumn 9, Issue 1, 2014, Pages

Metabotropic glutamate receptor-1 contributes to progression in triple negative breast cancer

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMIC ACID; LENTIVIRUS VECTOR; METABOTROPIC RECEPTOR 1; METABOTROPIC GLUTAMATE RECEPTOR TYPE 1; METABOTROPIC RECEPTOR;

EID: 84896762683     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0081126     Document Type: Article
Times cited : (43)

References (53)
  • 5
    • 84877028141 scopus 로고    scopus 로고
    • Comprehensive molecular portraits of human breast tumours
    • Cancer Genome Atlas Research N
    • Cancer Genome Atlas Research N (2012) Comprehensive molecular portraits of human breast tumours. Nature 490: 61-70.
    • (2012) Nature , vol.490 , pp. 61-70
  • 8
    • 79151476662 scopus 로고    scopus 로고
    • Triple negative breast cancer: Unmet medical needs
    • Pal SK, Childs BH, Pegram M (2011) Triple negative breast cancer: unmet medical needs. Breast Cancer Res Treat 125: 627-636.
    • (2011) Breast Cancer Res Treat , vol.125 , pp. 627-636
    • Pal, S.K.1    Childs, B.H.2    Pegram, M.3
  • 9
    • 84859107394 scopus 로고    scopus 로고
    • Metabotropic glutamate receptor-1: A potential therapeutic target for the treatment of breast cancer
    • Speyer CL, Smith JS, Banda M, DeVries JA, Mekani T, et al. (2012) Metabotropic glutamate receptor-1: a potential therapeutic target for the treatment of breast cancer. Breast Cancer Res Treat 132: 565-573.
    • (2012) Breast Cancer Res Treat , vol.132 , pp. 565-573
    • Speyer, C.L.1    Smith, J.S.2    Banda, M.3    Devries, J.A.4    Mekani, T.5
  • 10
    • 0032489519 scopus 로고    scopus 로고
    • Role of the second and third intracellular loops of metabotropic glutamate receptors in mediating dual signal transduction activation
    • DOI 10.1074/jbc.273.10.5615
    • Francesconi A, Duvoisin RM (1998) Role of the second and third intracellular loops of metabotropic glutamate receptors in mediating dual signal transduction activation. J Biol Chem 273: 5615-5624. (Pubitemid 28124031)
    • (1998) Journal of Biological Chemistry , vol.273 , Issue.10 , pp. 5615-5624
    • Francesconi, A.1    Duvoisin, R.M.2
  • 11
    • 0035398487 scopus 로고    scopus 로고
    • G-protein-coupled receptors and signaling networks: Emerging paradigms
    • DOI 10.1016/S0165-6147(00)01678-3, PII S0165614700016783
    • Marinissen MJ, Gutkind JS (2001) G-protein-coupled receptors and signaling networks: emerging paradigms. Trends Pharmacol Sci 22: 368-376. (Pubitemid 32592476)
    • (2001) Trends in Pharmacological Sciences , vol.22 , Issue.7 , pp. 368-376
    • Marinissen, M.J.1    Gutkind J.Silvio2
  • 12
  • 13
    • 2342509663 scopus 로고    scopus 로고
    • The role of G-protein coupled receptors and associated proteins in receptor tyrosine kinase signal transduction
    • DOI 10.1016/j.semcdb.2003.12.020, PII S1084952103001253
    • Waters C, Pyne S, Pyne NJ (2004) The role of G-protein coupled receptors and associated proteins in receptor tyrosine kinase signal transduction. Semin Cell Dev Biol 15: 309-323. (Pubitemid 38581999)
    • (2004) Seminars in Cell and Developmental Biology , vol.15 , Issue.3 , pp. 309-323
    • Waters, C.1    Pyne, S.2    Pyne, N.J.3
  • 16
    • 33947213963 scopus 로고    scopus 로고
    • Metabotropic glutamate receptor 1 and glutamate signaling in human melanoma
    • DOI 10.1158/0008-5472.CAN-06-3665
    • Namkoong J, Shin SS, Lee HJ, Marin YE, Wall BA, et al. (2007) Metabotropic glutamate receptor 1 and glutamate signaling in human melanoma. Cancer Res 67: 2298-2305. (Pubitemid 46424250)
    • (2007) Cancer Research , vol.67 , Issue.5 , pp. 2298-2305
    • Namkoong, J.1    Shin, S.-S.2    Hwa, J.L.3    Marin, Y.E.4    Wall, B.A.5    Goydos, J.S.6    Chen, S.7
  • 17
    • 43549096176 scopus 로고    scopus 로고
    • Oncogenic activities of metabotropic glutamate receptor 1 (Grm1) in melanocyte transformation
    • DOI 10.1111/j.1755-148X.2008.00452.x
    • Shin SS, Namkoong J, Wall BA, Gleason R, Lee HJ, et al. (2008) Oncogenic activities of metabotropic glutamate receptor 1 (Grm1) in melanocyte transformation. Pigment Cell Melanoma Res 21: 368-378. (Pubitemid 351678078)
    • (2008) Pigment Cell and Melanoma Research , vol.21 , Issue.3 , pp. 368-378
    • Shin, S.-S.1    Namkoong, J.2    Wall, B.A.3    Gleason, R.4    Lee, H.J.5    Chen, S.6
  • 18
    • 33646372468 scopus 로고    scopus 로고
    • Stimulation of oncogenic metabotropic glutamate receptor 1 in melanoma cells activates ERK1/2 via PKCε
    • DOI 10.1016/j.cellsig.2005.10.012, PII S0898656805002834
    • Marin YE, Namkoong J, Cohen-Solal K, Shin SS, Martino JJ, et al. (2006) Stimulation of oncogenic metabotropic glutamate receptor 1 in melanoma cells activates ERK1/2 via PKCepsilon. Cell Signal 18: 1279-1286. (Pubitemid 43674044)
    • (2006) Cellular Signalling , vol.18 , Issue.8 , pp. 1279-1286
    • Marin, Y.E.1    Namkoong, J.2    Cohen-Solal, K.3    Shin, S.-S.4    Martino, J.J.5    Oka, M.6    Chen, S.7
  • 19
    • 74349130963 scopus 로고    scopus 로고
    • AKT2 is a downstream target of metabotropic glutamate receptor 1 (Grm1)
    • Shin SS, Wall BA, Goydos JS, Chen S (2010) AKT2 is a downstream target of metabotropic glutamate receptor 1 (Grm1). Pigment Cell Melanoma Res 23: 103-111.
    • (2010) Pigment Cell Melanoma Res , vol.23 , pp. 103-111
    • Shin, S.S.1    Wall, B.A.2    Goydos, J.S.3    Chen, S.4
  • 20
    • 66649107219 scopus 로고    scopus 로고
    • A phase 0 trial of riluzole in patients with resectable stage III and IV melanoma
    • Yip D, Le MN, Chan JL, Lee JH, Mehnert JA, et al. (2009) A phase 0 trial of riluzole in patients with resectable stage III and IV melanoma. Clin Cancer Res 15: 3896-3902.
    • (2009) Clin Cancer Res , vol.15 , pp. 3896-3902
    • Yip, D.1    Le, M.N.2    Chan, J.L.3    Lee, J.H.4    Mehnert, J.A.5
  • 21
    • 84869990263 scopus 로고    scopus 로고
    • Rab8 modulates metabotropic glutamate receptor subtype 1 intracellular trafficking and signaling in a protein kinase C-dependent manner
    • Esseltine JL, Ribeiro FM, Ferguson SS (2012) Rab8 modulates metabotropic glutamate receptor subtype 1 intracellular trafficking and signaling in a protein kinase C-dependent manner. J Neurosci 32: 16933-16942a.
    • (2012) J Neurosci , vol.32
    • Esseltine, J.L.1    Ribeiro, F.M.2    Ferguson, S.S.3
  • 22
    • 84874699967 scopus 로고    scopus 로고
    • Somatic mutations in GRM1 in cancer alter metabotropic glutamate receptor 1 intracellular localization and signaling
    • Esseltine JL, Willard MD, Wulur IH, Lajiness ME, Barber TD, et al. (2013) Somatic Mutations in GRM1 in Cancer Alter Metabotropic Glutamate Receptor 1 Intracellular Localization and Signaling. Mol Pharmacol 83: 770-780.
    • (2013) Mol Pharmacol , vol.83 , pp. 770-780
    • Esseltine, J.L.1    Willard, M.D.2    Wulur, I.H.3    Lajiness, M.E.4    Barber, T.D.5
  • 23
    • 77953503937 scopus 로고    scopus 로고
    • Riluzole, neuroprotection and amyotrophic lateral sclerosis
    • Cheah BC, Vucic S, Krishnan AV, Kiernan MC (2010) Riluzole, neuroprotection and amyotrophic lateral sclerosis. Curr Med Chem 17: 1942-1199.
    • (2010) Curr Med Chem , vol.17 , pp. 1942-1199
    • Cheah, B.C.1    Vucic, S.2    Krishnan, A.V.3    Kiernan, M.C.4
  • 26
    • 39449095723 scopus 로고    scopus 로고
    • Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype
    • DOI 10.1158/0008-5472.CAN-07-2017
    • Sarrió D, Rodriguez-Pinilla SM, Hardisson D, Cano A, Moreno-Bueno G, et al. (2008) Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype. Cancer Res 68: 989-997. (Pubitemid 351272216)
    • (2008) Cancer Research , vol.68 , Issue.4 , pp. 989-997
    • Sarrio, D.1    Rodriguez-Pinilla, S.M.2    Hardisson, D.3    Cano, A.4    Moreno-Bueno, G.5    Palacios, J.6
  • 27
    • 77950114803 scopus 로고    scopus 로고
    • Delineating genetic alterations for tumor progression in the MCF10A series of breast cancer cell lines
    • Kadota M, Yang HH, Gomez B, Sato M, Clifford RJ, et al. (2010) Delineating genetic alterations for tumor progression in the MCF10A series of breast cancer cell lines. PLoS One 5: e9201.
    • (2010) PLoS One , vol.5
    • Kadota, M.1    Yang, H.H.2    Gomez, B.3    Sato, M.4    Clifford, R.J.5
  • 28
    • 0034458577 scopus 로고    scopus 로고
    • Xenograft models of premalignant breast disease
    • DOI 10.1023/A:1009577811584
    • Miller FR (2000) Xenograft models of premalignant breast disease. J Mammary Gland Biol Neoplasia 5: 379-391. (Pubitemid 32236769)
    • (2000) Journal of Mammary Gland Biology and Neoplasia , vol.5 , Issue.4 , pp. 379-391
    • Miller, F.R.1
  • 29
    • 41649085584 scopus 로고    scopus 로고
    • P21-Activated kinase 1 coordinates aberrant cell survival and pericellular proteolysis in a threedimensional culture model for premalignant progression of human breast cancer
    • Li Q, Mullins SR, Sloane BF, Mattingly RR (2008) p21-Activated kinase 1 coordinates aberrant cell survival and pericellular proteolysis in a threedimensional culture model for premalignant progression of human breast cancer. Neoplasia 10: 314-329.
    • (2008) Neoplasia , vol.10 , pp. 314-329
    • Li, Q.1    Mullins, S.R.2    Sloane, B.F.3    Mattingly, R.R.4
  • 30
    • 84869389974 scopus 로고    scopus 로고
    • Threedimensional cultures model premalignant progression of human breast epithelial cells: Role of cysteine cathepsins
    • press
    • Mullins SR, Sameni M, Blum G, Bogyo M, Sloane BF, et al. (2012) Threedimensional cultures model premalignant progression of human breast epithelial cells: role of cysteine cathepsins. Biol Chem: In press.
    • (2012) Biol Chem
    • Mullins, S.R.1    Sameni, M.2    Blum, G.3    Bogyo, M.4    Sloane, B.F.5
  • 31
    • 0030044330 scopus 로고    scopus 로고
    • MCF10AT: A model for the evolution of cancer from proliferative breast disease
    • Dawson PJ, Wolman SR, Tait L, Heppner GH, Miller FR (1996) MCF10AT: a model for the evolution of cancer from proliferative breast disease. Am J Pathol 148: 313-319.
    • (1996) Am J Pathol , vol.148 , pp. 313-319
    • Dawson, P.J.1    Wolman, S.R.2    Tait, L.3    Heppner, G.H.4    Miller, F.R.5
  • 34
    • 0141721698 scopus 로고    scopus 로고
    • Differential expression of vascular endothelial growth factor-A isoforms at different stages of melanoma progression
    • DOI 10.1016/S1072-7515(03)00388-0, PII S1072751503003880
    • Gorski DH, Leal AD, Goydos JS (2003) Differential expression of vascular endothelial growth factor-A isoforms at different stages of melanoma progression. J Am Coll Surg 197: 408-418. (Pubitemid 38373300)
    • (2003) Journal of the American College of Surgeons , vol.197 , Issue.3 , pp. 408-418
    • Gorski, D.H.1    Leal, A.D.2    Goydos, J.S.3
  • 35
    • 0347995048 scopus 로고    scopus 로고
    • Vascular Endothelial Growth Factor C mRNA Expression Correlates with Stage of Progression in Patients with Melanoma
    • Goydos JS, Gorski DH (2003) Vascular endothelial growth factor C mRNA expression correlates with stage of progression in patients with melanoma. Clin Cancer Res 9: 5962-5967. (Pubitemid 38018082)
    • (2003) Clinical Cancer Research , vol.9 , Issue.16 , pp. 5962-5967
    • Goydos, J.S.1    Gorski, D.H.2
  • 36
    • 84857824501 scopus 로고    scopus 로고
    • MAME models for 4D live-cell imaging of tumor: Microenvironment interactions that impact malignant progression
    • Sameni M, Anbalagan A, Olive MB, Moin K, Mattingly RR, et al. (2012) MAME models for 4D live-cell imaging of tumor: microenvironment interactions that impact malignant progression. J Vis Exp 60: e3661-e3665.
    • (2012) J Vis Exp , vol.60
    • Sameni, M.1    Anbalagan, A.2    Olive, M.B.3    Moin, K.4    Mattingly, R.R.5
  • 37
    • 0024376173 scopus 로고
    • Ras Oncogenes in human cancer: A review
    • Bos JL (1989) ras oncogenes in human cancer: a review. Cancer Res 49: 4682-4689. (Pubitemid 19213607)
    • (1989) Cancer Research , vol.49 , Issue.17 , pp. 4682-4689
    • Bos, J.L.1
  • 38
    • 0022845633 scopus 로고
    • Ras gene alterations and enhanced levels of ras p21 expression in a spectrum of benign and malignant human mammary tissues
    • Thor A, Ohuchi N, Hand PH, Callahan R, Weeks MO, et al. (1986) ras gene alterations and enhanced levels of ras p21 expression in a spectrum of benign and malignant human mammary tissues. Lab Invest 55: 603-615. (Pubitemid 17231126)
    • (1986) Laboratory Investigation , vol.55 , Issue.6 , pp. 603-615
    • Thor, A.1    Ohuchi, N.2    Horan Hand, P.3
  • 39
    • 0034686626 scopus 로고    scopus 로고
    • MCF10DCIS.com xenograft model of human comedo ductal carcinoma in situ
    • Miller FR, Santner SJ, Tait L, Dawson PJ (2000) MCF10DCIS.com xenograft model of human comedo ductal carcinoma in situ. J Natl Cancer Inst 92: 1185-1186.
    • (2000) J Natl Cancer Inst , vol.92 , pp. 1185-1186
    • Miller, F.R.1    Santner, S.J.2    Tait, L.3    Dawson, P.J.4
  • 41
    • 33645229443 scopus 로고    scopus 로고
    • Highresolution mapping of molecular events associated with immortalization, transformation, and progression to breast cancer in the MCF10 model
    • Worsham MJ, Pals G, Schouten JP, Miller F, Tiwari N, et al. (2006) Highresolution mapping of molecular events associated with immortalization, transformation, and progression to breast cancer in the MCF10 model. Breast Cancer Res Treat 96: 177-186.
    • (2006) Breast Cancer Res Treat , vol.96 , pp. 177-186
    • Worsham, M.J.1    Pals, G.2    Schouten, J.P.3    Miller, F.4    Tiwari, N.5
  • 42
    • 0035222855 scopus 로고    scopus 로고
    • The Ras Signaling Pathway in Mammary Tumorigenesis and Metastasis
    • DOI 10.1023/A:1009572700317
    • Malaney S, Daly RJ (2001) The ras signaling pathway in mammary tumorigenesis and metastasis. J Mammary Gland Biol Neoplasia 6: 101-113. (Pubitemid 33640649)
    • (2001) Journal of Mammary Gland Biology and Neoplasia , vol.6 , Issue.1 , pp. 101-113
    • Malaney, S.1    Daly, R.J.2
  • 43
    • 69449096782 scopus 로고    scopus 로고
    • BMI1 cooperates with H-RAS to induce an aggressive breast cancer phenotype with brain metastases
    • Hoenerhoff MJ, Chu I, Barkan D, Liu ZY, Datta S, et al. (2009) BMI1 cooperates with H-RAS to induce an aggressive breast cancer phenotype with brain metastases. Oncogene 28: 3022-3032.
    • (2009) Oncogene , vol.28 , pp. 3022-3032
    • Hoenerhoff, M.J.1    Chu, I.2    Barkan, D.3    Liu, Z.Y.4    Datta, S.5
  • 45
    • 25444443688 scopus 로고    scopus 로고
    • Modelling glandular epithelial cancers in three-dimensional cultures
    • DOI 10.1038/nrc1695, PII N1695
    • Debnath J, Brugge JS (2005) Modelling glandular epithelial cancers in threedimensional cultures. Nat Rev Cancer 5: 675-688. (Pubitemid 41486361)
    • (2005) Nature Reviews Cancer , vol.5 , Issue.9 , pp. 675-688
    • Debnath, J.1    Brugge, J.S.2
  • 46
    • 0026669724 scopus 로고
    • Additive effects of c-erbB-2, c-Ha-ras, and transforming growth factor-alpha genes on in vitro transformation of human mammary epithelial cells
    • Ciardiello F, Gottardis M, Basolo F, Pepe S, Normanno N, et al. (1992) Additive effects of c-erbB-2, c-Ha-ras, and transforming growth factor-alpha genes on in vitro transformation of human mammary epithelial cells. Mol Carcinog 6: 43-52.
    • (1992) Mol Carcinog , vol.6 , pp. 43-52
    • Ciardiello, F.1    Gottardis, M.2    Basolo, F.3    Pepe, S.4    Normanno, N.5
  • 47
    • 23644458595 scopus 로고    scopus 로고
    • Grm5 expression is not required for the oncogenic role of Grm1 in melanocytes
    • DOI 10.1016/j.neuropharm.2005.05.018, PII S0028390805002133
    • Marin YE, Namkoong J, Shin SS, Raines J, Degenhardt K, et al. (2005) Grm5 expression is not required for the oncogenic role of Grm1 in melanocytes. Neuropharmacology 49 Suppl 1: 70-79. (Pubitemid 41115894)
    • (2005) Neuropharmacology , vol.49 , Issue.SUPPL. , pp. 70-79
    • Marin, Y.E.1    Namkoong, J.2    Shin, S.-S.3    Raines, J.4    Degenhardt, K.5    White, E.6    Chen, S.7
  • 48
    • 49949117480 scopus 로고    scopus 로고
    • Metabotropic glutamate receptors (mGlus) and cellular transformation
    • Shin SS, Martino JJ, Chen S (2008) Metabotropic glutamate receptors (mGlus) and cellular transformation. Neuropharmacology 55: 396-402.
    • (2008) Neuropharmacology , vol.55 , pp. 396-402
    • Shin, S.S.1    Martino, J.J.2    Chen, S.3
  • 50
    • 0033830726 scopus 로고    scopus 로고
    • A novel neuroprotective mechanism of riluzole: Direct inhibition of protein kinase C
    • Noh KM, Hwang JY, Shin HC, Koh JY (2000) A novel neuroprotective mechanism of riluzole: direct inhibition of protein kinase C. Neurobiol Dis 7: 375-383.
    • (2000) Neurobiol Dis , vol.7 , pp. 375-383
    • Noh, K.M.1    Hwang, J.Y.2    Shin, H.C.3    Koh, J.Y.4
  • 51
    • 0033713305 scopus 로고    scopus 로고
    • Selective depression of low-release probability excitatory synapses by sodium channel blockers
    • Prakriya M, Mennerick S (2000) Selective depression of low-release probability excitatory synapses by sodium channel blockers. Neuron 26: 671-682.
    • (2000) Neuron , vol.26 , pp. 671-682
    • Prakriya, M.1    Mennerick, S.2
  • 52
    • 1642462299 scopus 로고    scopus 로고
    • Mechanisms underlying the riluzole inhibition of glutamate release from rat cerebral cortex nerve terminals (synaptosomes)
    • Wang SJ, Wang KY, Wang WC (2004) Mechanisms underlying the riluzole inhibition of glutamate release from rat cerebral cortex nerve terminals (synaptosomes). Neuroscience 125: 191-201.
    • (2004) Neuroscience , vol.125 , pp. 191-201
    • Wang, S.J.1    Wang, K.Y.2    Wang, W.C.3
  • 53
    • 84862526929 scopus 로고    scopus 로고
    • The clonal and mutational evolution spectrum of primary triple-negative breast cancers
    • Shah SP, Roth A, Goya R, Oloumi A, Ha G, et al. (2012) The clonal and mutational evolution spectrum of primary triple-negative breast cancers. Nature.
    • (2012) Nature.
    • Shah, S.P.1    Roth, A.2    Goya, R.3    Oloumi, A.4    Ha, G.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.